AVTR vs CVS · P/E 13, rev $6.55B vs P/E 16, rev $402.07B
Avantor Inc (AVTR) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Avantor Inc (AVTR) is a medical instruments & supplies company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported AVTR revenue for 2025-12-31 was $6.55B. Net income was -$530.2M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
AVTR currently screens at market cap $9.36B and trailing P/E 13.3. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the AVTR and CVS stock pages for the full models.
Not investment advice.